Genetics of dementia

Medical Clinics of North America

Volumn 86, Issue 3, 2002, Pages 591-614

  Tsuang, Debby W ^a,b   Bird, Thomas D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2;

AGE; AGED; AGING; AMNESIA; CHROMOSOME 1; CHROMOSOME 14; CLINICAL FEATURE; COGNITIVE DEFECT; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ACTIVITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FAMILIAL DISEASE; GENE FUNCTION; GENE MAPPING; GENE MUTATION; HEREDITY; HUMAN; HUNTINGTON CHOREA; LEWY BODY; MOLECULAR CLONING; MOLECULAR GENETICS; MULTIINFARCT DEMENTIA; MUTATIONAL ANALYSIS; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; REVIEW; SYMPTOM;

ADULT; AGED; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOLIPOPROTEINS E; DEMENTIA; FEMALE; HUMANS; HUNTINGTON DISEASE; LEWY BODIES; LINKAGE (GENETICS); MALE; MIDDLE AGED; PICK DISEASE OF THE BRAIN; PRION DISEASES; RISK;

EID: 0036327136     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00003-2     Document Type: Review

References (112)

1. Ueber eigenartigen krankheitsfalle des spateren alters
2. Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study
3. Recent advances in the genetics of Alzheimer's disease
4. Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses. European studies of dementia
5. The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study
6. Association between Alzheimer's disease and Down syndrome: Neuropathological observations
7. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
8. Phenotypic heterogeneity of familial Alzheimer's disease: A study of 24 kindreds
9. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing
10. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease
11. Regulation of APP cleavage by alpha-, beta- and gamma-secretases
12. Biochemical detection of Abeta isoforms: Implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease
13. Alzheimer's disease: Genes, proteins, and therapy
14. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis
15. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
16. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
17. Presenilin mutations in Alzheimer's disease
18. In search of gamma-secretase: Presenilin at the cutting edge
19. Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia
20. Chromosome 14-encoded Alzheimer's disease: Genetic and clinicopathological description
21. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred
22. Variant Alzheimer's disease with spastic paraparesis: Clinical characterization
23. A familial Alzheimer's disease locus on chromosome 1
24. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene
25. Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage
26. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
27. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
28. Apolipoprotein E: Risk factor for Alzheimer disease
29. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: The Cache County Study
30. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis
31. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease
32. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City
33. Alzheimer's disease, apolipoprotein E4, and gender
34. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
35. Apolipoprotein E in Southern Italy: Protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease
36. Apolipoprotein E genotyping as a diagnostic adjunct for Alzheimer's disease
37. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series
38. The genetics of Alzheimer's disease
39. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
40. Genetic association studies between dementia of the Alzheimer's type and three receptors of apolipoprotein E in a Caucasian population
41. No association between the alpha-2 macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression
42. Alpha-2 macroglobulin gene and Alzheimer disease
43. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
44. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
45. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
46. Psychiatric morbidity in dementia with Lewy bodies: A prospective clinical and neuropathological comparative study with Alzheimer's disease
47. Familial parkinsonism, dementia, and Lewy body disease: Study of family G
48. Familial dementia with Lewy bodies (DLB)
49. Familial parkinsonism with synuclein pathology: Clinical and PET studies of A30P mutation carriers
50. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation
51. Association between early-onset Parkinson's disease and mutations in the parkin gene
52. CADASIL syndrome: A genetic form of vascular dementia
53. De novo mutation in the Notch3 gene causing CADASIL
54. Differential diagnosis of dementia. The clinical process
55. Neuropathological classification of Huntington's disease
56. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
57. On chorea
58. Molecular genetics of Huntington's disease
59. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
60. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease
61. Trinucleotide repeat length instability and age of onset in Huntington's disease
62. Trinucleotide repeat elongation in the Huntington gene in Huntington disease patients from 71 Danish families
63. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease
64. Trinucleotide repeat expansion and neuropsychiatric disease
65. Clinical aspects of CAG repeat diseases
66. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease
67. Outrageous fortune: The risk of suicide in genetic testing for Huntington disease
68. Frontal lobe degeneration of non-Alzheimer type I. Neuropathology
69. Familial progressive aphasia: Its relationship to other forms of lobar atrophy
70. Dementia of frontal lobe type
71. Familial aggregation in frontotemporal dementia
72. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease
73. Diagnostic accuracy of Alzheimer's disease: A neuropathological study
74. Frontal lobe degeneration of non-Alzheimer type II. Clinical picture and differential diagnosis
75. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22
76. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration
77. Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala
78. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Conference participants
79. Tau is a candidate gene for chromosome 17 frontotemporal dementia
80. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
81. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
82. Phenotypic correlations in FTDP-17
83. Frontotemporal dementia genetics
84. Familial non-specific dementia maps to chromosome 3
85. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
86. Progressive supranuclear gaze palsy in linkage disequilibrium with tau and not the alpha-synuclein gene
87. Tau as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam
88. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia
89. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia
90. La maladie dite tremblante du mouton est-elle inoculable?
91. Uber eine eigenartige herdformige erkrankung des zentralnervensystems
92. Uber eigenartige erkrankungen des zentralnervensystems mit bemerkenswertem anatomischem befunde (spastische pseudosklerose-encephalomyelopathie mit disseminierten degenerationsherden)
93. Scrapie prion proteins are synthesized in neurons
94. The prion protein gene: A role in mouse embryogenesis?
95. Developmental expression of the prion protein gene in glial cells
96. Molecular biology and genetics of prion diseases
97. The prion diseases: Creutzfeldt-Jakob, Gerstmann-Straussler-Scheinker, and related disorders
98. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD)
99. Conclusions of the symposium
100. Prion diseases
101. Gerstmann-Straussler-Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients
102. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome
103. Transmission of spongiform encephalopathy from a familial Creutzfeldt-Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation
104. Mitochondrial involvement in Alzheimer's disease
105. Point mutations of the mtDNA control region in normal and neurodegenerative human brains